This ACS-funded study is adapting an existing mindfulness-based intervention (FOCUS) to a smartphone app for caregivers of patients receiving a BMT. We are recruiting caregivers of patients undergoing BMT to receive their feedback on the app, as well as to measure benchmarks of feasibility, acceptability, and engagement data.
Funding Source: ACS Discovery Boost (Development of a Mindfulness-based Smartphone Application for BMT Caregivers)
COMPASS is an NIH-funded study that is testing the efficacy of a mindfulness-based intervention among caregivers of allogeneic hematopoietic stem cell transplant patients. Caregivers are randomized to one of three treatment conditions and caregiver burden, patient distress, and patient healthcare utilization are being examined.
Funding Source: R01CA255265 (Efficacy of a Mindfulness-based Management Program for Allogeneic HCT Caregivers)
The primary aim of this study was to develop and pilot test a mindfulness-based program for caregivers of allogeneic onomatopoetic stem cell transplant patients to examine changes on variables associated with reduced stress. We evaluated benchmarks of feasibility and acceptability of the program as well as collected and analyzed data on variables associated with reduced stress.
Funding Source: Moffitt Innovation Award (Development of a Mindfulness-based Management Program for HCT Caregivers)
AutoFOCUS tested a novel, mindfulness-based program (FOCUS) among autologous hematopoietic cell transplant (HCT) caregivers. We recruited caregivers of patients undergoing an autologous transplant to receive their feedback on the program, as well as to measure benchmarks of feasibility and acceptability.
Funding Source: Innovation Award (AutoFOCUS: A Mindfulness-Based Intervention for Autologous HCT Cancer Caregivers)